Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia.
Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, Victoria, 3000, Australia.
Ann Surg Oncol. 2022 Nov;29(12):7911-7920. doi: 10.1245/s10434-022-12057-3. Epub 2022 Jul 6.
Pre-clinical studies indicate that dry-cold-carbon-dioxide (DC-CO2) insufflation leads to more peritoneal damage, inflammation and hypothermia compared with humidified-warm-CO (HW-CO2). Peritoneum and core temperature in patients undergoing colorectal cancer (CRC) surgery were compared.
Sixty-six patients were randomized into laparoscopic groups; those insufflated with DC-CO2 or HW-CO2. A separate group of nineteen patients undergoing laparotomy were randomised to conventional surgery or with the insertion of a device delivering HW-CO2. Temperatures were monitored and peritoneal biopsies and bloods were taken at the start of surgery, at 1 and 3 h. Further bloods were taken depending upon hospital length-of-stay (LOS). Peritoneal samples were subjected to scanning electron microscopy to evaluate mesothelial damage.
Laparoscopic cases experienced a temperature drop despite Bair-Hugger use. HW-CO2 restored normothermia (≥ 36.5 °C) by 3 h, DC-CO2 did not. LOS was shorter for colon compared with rectal cancer cases and if insufflated with HW-CO2 compared with DC-CO2; 5.0 vs 7.2 days, colon and 11.6 vs 15.4 days rectum, respectively. Unexpectedly, one third of patients had pre-existing damage. Damage increased at 1 and 3 h to a greater extent in the DC-CO2 compared with the HW-CO2 laparoscopic cohort. C-reactive protein levels were higher in open than laparoscopic cases and lower in both matched HW-CO2 groups.
This prospective RCT is in accord with animal studies while highlighting pre-existing damage in some patients. Peritoneal mesothelium protection, reduced inflammation and restoration of core-body temperature data suggest benefit with the use of HW-CO2 in patients undergoing CRC surgery.
临床前研究表明,与湿化-加温-二氧化碳(HW-CO2)相比,干冷-二氧化碳(DC-CO2)注气导致更多的腹膜损伤、炎症和低体温。比较了接受结直肠癌(CRC)手术的患者的腹膜和核心体温。
66 名患者随机分为腹腔镜组;那些用 DC-CO2 或 HW-CO2 充气的患者。另一组 19 名接受剖腹手术的患者随机分为常规手术组或插入输送 HW-CO2 的装置组。在手术开始时、1 小时和 3 小时监测体温,并采集腹膜活检和血液。根据住院时间(LOS)进一步采集血液。将腹膜样本进行扫描电子显微镜检查,以评估间皮损伤。
尽管使用了 Bair-Hugger,但腹腔镜病例仍出现体温下降。HW-CO2 在 3 小时内恢复正常体温(≥36.5°C),而 DC-CO2 则没有。与 DC-CO2 相比,HW-CO2 充气的结肠癌病例的 LOS 更短,为 5.0 天,而直肠癌病例的 LOS 为 7.2 天;分别为 11.6 天和 15.4 天。出乎意料的是,三分之一的患者存在预先存在的损伤。在 DC-CO2 腹腔镜组中,1 小时和 3 小时时的损伤比 HW-CO2 腹腔镜组更严重。与腹腔镜病例相比,开放性病例的 C-反应蛋白水平更高,而与两个匹配的 HW-CO2 组相比,其水平更低。
这项前瞻性 RCT 与动物研究一致,同时强调了一些患者存在预先存在的损伤。腹膜间皮保护、减少炎症和恢复核心体温数据表明,HW-CO2 在接受 CRC 手术的患者中具有益处。